TELOMERASE-PEPTIDE VACCINE TOGETHER WITH GEMCITABINE IN ADVANCED PANCREATIC CANCER PATIENTS

被引：0
|
作者：
Staff, C. E. B. [1 ]
Mozaffari, F. M. [1 ]
Liljefors, M. [1 ]
Mosolits, S. [1 ]
Frodin, J. [1 ]
Choudhury, A. [1 ]
Mellstedt, H. [1 ]
机构：
[1] Karolinska Inst, Stockholm, Sweden
来源：
ANNALS OF ONCOLOGY | 2010年 / 21卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：26 / 26
页数：1
相关论文
共 50 条
  • [41] Flashback Foreword: Gemcitabine for Advanced Pancreatic Cancer
    O'Reilly, Eileen M.
    Ko, Andrew H.
    Friedberg, Jonathan W.
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (36) : 5479 - +
  • [42] Activity of raltitrexed and gemcitabine in advanced pancreatic cancer
    Kralidis, E
    Aebi, S
    Friess, H
    Büchler, MW
    Borner, MM
    ANNALS OF ONCOLOGY, 2003, 14 (04) : 574 - 579
  • [43] Monotherapy with gemcitabine in patients with advanced pancreatic carcinoma
    Petrovic, Z
    Jovic, J
    Perisic, N
    Brocic-Pecelj, T
    Lukacevic, S
    ANNALS OF ONCOLOGY, 1998, 9 : 167 - 167
  • [44] Phase III Randomized Comparison of Gemcitabine Versus Gemcitabine Plus Capecitabine in Patients With Advanced Pancreatic Cancer
    Cunningham, David
    Chau, Ian
    Stocken, Deborah D.
    Valle, Juan W.
    Smith, David
    Steward, William
    Harper, Peter G.
    Dunn, Janet
    Tudur-Smith, Catrin
    West, Julia
    Falk, Stephen
    Crellin, Adrian
    Adab, Fawzi
    Thompson, Joyce
    Leonard, Pauline
    Ostrowski, Joe
    Eatock, Martin
    Scheithauer, Werner
    Herrmann, Richard
    Neoptolemos, John P.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (33) : 5513 - 5518
  • [45] A PILOT TRIAL OF GEMCITABINE IN COMBINATION WITH CAPECITABINE OR ERLOTINIB COMPARED TO GEMCITABINE ALONE IN PATIENTS WITH ADVANCED PANCREATIC CANCER
    Cho, J. Y.
    Lim, J. Y.
    Lee, S. J.
    Lee, D. K.
    Park, J. S.
    Yoon, D. S.
    Min, Y. H.
    ANNALS OF ONCOLOGY, 2012, 23 : 240 - 240
  • [46] A phase I study of erlotinib, bevacizumab and gemcitabine in patients with advanced pancreatic cancer
    Gomez-Martin, C.
    Camara, J. C.
    Cortes, H.
    Jara, C.
    Gravalos, C.
    Rubio, B.
    Amador, M. L.
    Hidalgo, M.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [47] Clinical and Immune Effects of Lenalidomide in Combination with Gemcitabine in Patients with Advanced Pancreatic Cancer
    Ullenhag, Gustav J.
    Mozaffari, Fariba
    Broberg, Mats
    Mellstedt, Hakan
    Liljefors, Maria
    PLOS ONE, 2017, 12 (01):
  • [48] A Phase II Trial of Gemcitabine plus Capecitabine for Patients with Advanced Pancreatic Cancer
    Choi, Jong Gwon
    Seo, Jae Hong
    Oh, Sang Cheul
    Choi, Chul Won
    Kim, Jun Suk
    CANCER RESEARCH AND TREATMENT, 2012, 44 (02): : 127 - 132
  • [49] Phase II study of gemcitabine, UFT and leucovorin in patients with advanced pancreatic cancer
    Kim, TW
    Kang, HJ
    Ahn, JH
    Lee, K
    Chang, HM
    Kang, YK
    Lee, JS
    ACTA ONCOLOGICA, 2002, 41 (7-8) : 689 - 694
  • [50] Reinitiating nab-paclitaxel plus gemcitabine in patients with advanced pancreatic cancer
    Borazanci, Erkut
    Schroeder, Katy
    Jameson, Gayle S.
    Ramanathan, Ramesh K.
    Von Hoff, Daniel D.
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (03)
12345